ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
125.01
+5.37 (4.49%)
At close: Jan 14, 2026, 4:00 PM EST
124.90
-0.11 (-0.09%)
After-hours: Jan 14, 2026, 6:20 PM EST
ABIVAX Société Anonyme Employees
ABIVAX Société Anonyme had 69 employees as of December 31, 2024. The number of employees increased by 8 or 13.11% compared to the previous year.
Employees
69
Change (1Y)
8
Growth (1Y)
13.11%
Revenue / Employee
$90,310
Profits / Employee
-$4,991,098
Market Cap
9.80B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 69 | 8 | 13.11% |
| Dec 31, 2023 | 61 | 37 | 154.17% |
| Dec 31, 2022 | 24 | 0 | - |
| Dec 31, 2021 | 24 | -3 | -11.11% |
| Dec 31, 2020 | 27 | 1 | 3.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ABVX News
- 2 days ago - Abivax: Don't Just Buy The Rumor, Buy The Fundamentals - Seeking Alpha
- 2 days ago - France has had no request for investment approval in biotech Abivax - official - Reuters
- 2 days ago - Abivax stock rockets 30% on Eli Lilly takeover speculation - Invezz
- 2 days ago - Abivax Surges on Report Eli Lilly is Preparing $17.5 Billion Bid - WSJ
- 2 days ago - Abivax shares soar 23% as media report reignites M&A chatter - Reuters
- 5 days ago - A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last year - CNBC
- 7 days ago - Abivax Provides 2026 Corporate Outlook - GlobeNewsWire
- 22 days ago - Abivax: Here's Why Eli Lilly Could Want Its Oral Ulcerative Colitis Therapy - Seeking Alpha